Innate Pharma S.A. | Balance Sheet
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
41,349.00
69,238.00
235,910.00
197,688.00
116,110.00
167,531
Total Accounts Receivable
7,061.00
8,586.00
9,948.00
25,554.00
15,084.00
59,337
Inventories
179.00
328.00
278.00
513.00
-
-
Other Current Assets
761.00
1,162.00
5,990.00
6,323.00
6,327.00
92,775
Total Current Assets
49,350.00
79,314.00
252,126.00
230,078.00
137,521.00
319,643
Net Property, Plant & Equipment
6,258.00
5,931.00
6,304.00
9,094.00
10,729.00
10,216
Total Investments and Advances
272.00
-
37,794.00
31,441.00
58,423.00
33,138
Intangible Assets
-
5,362.00
9,732.00
9,075.00
46,192.00
84,529
Other Assets
2.00
83.00
-
1,889.00
2,158.00
2,129
Total Assets
55,882.00
90,690.00
305,956.00
281,577.00
255,023.00
451,216
ST Debt & Current Portion LT Debt
613.00
453.00
622.00
889.00
968.00
Accounts Payable
5,141.00
6,846.00
15,107.00
15,599.00
19,970.00
Other Current Liabilities
3,524.00
3,476.00
44,434.00
59,953.00
52,971.00
Total Current Liabilities
9,278.00
10,775.00
60,163.00
76,441.00
73,909.00
Long-Term Debt
4,206.00
3,753.00
3,132.00
3,013.00
3,773.00
Provision for Risks & Charges
788.00
1,094.00
1,740.00
2,554.00
3,633.00
Other Liabilities
1,324.00
442.00
168,854.00
113,400.00
87,752.00
Total Liabilities
15,596.00
16,064.00
233,889.00
195,408.00
169,067.00
Common Equity (Total)
40,286.00
74,626.00
72,067.00
86,169.00
85,956.00
Total Shareholders' Equity
40,286.00
74,626.00
72,067.00
86,169.00
85,956.00
Total Equity
40,286.00
74,626.00
72,067.00
86,169.00
85,956.00
Liabilities & Shareholders' Equity
55,882.00
90,690.00
305,956.00
281,577.00
255,023.00
About Innate Pharma
View Profile
